慢性鼻窦炎手术扩大范围与持续疾病控制:一项回顾性手术队列研究
该回顾性队列研究纳入172例接受内镜鼻窦手术的慢性鼻窦炎伴鼻息肉患者,按LOEM系统(t1–t4)分类并随访3年。结果显示,更广泛的ESS(LOEM t3–t4)与显著降低的升级风险和延长疾病控制相关,尤其在翻修手术及嗜酸性粒细胞>300cells/μL等亚组中获益更明显。
要点
- 更广泛ESS(LOEM t3–t4)可降低治疗升级风险并延长疾病控制。
- 基线SNOT-22较高是ESS后治疗升级的独立预测因素。
- 翻修手术及嗜酸性粒细胞>300cells/μL患者从广泛ESS中获益更大。
核心结论
- 手术范围可能影响治疗升级的风险和时机,更广泛的ESS可能提供更持久的控制。
研究设计与样本
- 回顾性队列研究,纳入172例接受ESS的CRSwNP患者,按LOEM系统(t1–t4)分类,随访3年。
主要发现
- 需要升级治疗的患者SNOT-22评分更高且嗅觉功能更差。
- 更广泛的ESS(LOEM t3–t4)与显著降低的升级风险和延长疾病控制相关。
- 事后分析证实广泛手术(t3–t4)优于有限手术(t1–t2)的显著成对差异。
- 亚组分析显示在老年、特应性、翻修手术及嗜酸性粒细胞>300cells/μL患者中获益更大。
- 较高的基线SNOT-22评分是ESS后升级的独立预测因素。
临床怎么用
- 可考虑将手术范围纳入个性化治疗算法,对翻修病例及生物标志物定义亚组更广泛ESS可能更获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of endoscopic sinus surgery (ESS) extent on long-term disease control and therapeutic escalation in chronic rhinosinusitis with nasal polyps (CRSwNP) remains unclear. This study aims to evaluate the clinical applicability of endoscopy-based criteria for therapeutic escalation and to determine the impact of surgical extent on the risk and timing of treatment intensification. METHODS: A retrospective cohort study with 3-year follow-up was conducted. CRSwNP patients who underwent ESS were included and classified according to Lamella Ostium Extent Mucosa (LOEM) system (t1â€"t4). Baseline characteristics and disease severity measures were assessed. Therapeutic escalation was defined by endoscopic criteria. Predictors of escalation and the effect of ESS extent on escalation timing across clinical phenotypes were analyzed using multivariate logistic regression, Kaplan-Meier curves and Cox regressions. RESULTS: In the overall sample (n=172), patients who required escalation showed higher SNOT-22 scores and poorer olfactory function. More extensive ESS (LOEM t3â€"t4) was associated with significantly reduced escalation risk and prolonged disease control. Post hoc analyses confirmed significant pairwise differences favoring extensive (t3â€"t4) over limited (t1â€"t2) surgery. Subgroup analyses demonstrated greater benefits in older subjects, atopic patients, revision surgeries and patients with eosinophils >300cells/μL. Higher baseline SNOT-22 scores remained an independent predictor of escalation after ESS. CONCLUSIONS: Surgical extent appears to influence both escalation risk and timing. More extensive ESS may provide more sustained control, particularly in revision cases and biomarker-defined subgroups, supporting its integration into personalized algorithms.
引用
- Clari-Comes M, Martin-Jimenez D, Moreno-Luna R, et al. Treatment escalation and sustained disease control in chronic rhinosinusitis: a retrospective surgical cohort study. Rhinology. 2026. PMID: 41486815. doi:10.4193/Rhin25.301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。